United States · FDA National Drug Code directory
NOREPINEPHRINE BITARTRATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0338-0112_b40627c0-67bf-4740-9d21-83054aa6afd9
- Product NDC
- 0338-0112
- Form
- INJECTION, SOLUTION
- Composition / generic term
- norepinephrine bitartrate
- Labeler
- Baxter Healthcare Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 20210115
- Source listing expiry
- 20271231
Source-listed ingredients
- NOREPINEPHRINE BITARTRATE — 4 mg/250mL
These values do not establish equivalence or a dose recommendation.
Packages
- 20 BAG in 1 CARTON (0338-0112-20) / 250 mL in 1 BAG · 0338-0112-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →